Philip Astley-Sparke
Board Member
enGene Therapeutics Inc. (ENGN)Equibles does not estimate personal net worth.
Get an email with a short summary when enGene Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get ENGN alertsAbout Philip Astley-Sparke
Philip Astley-Sparke is recorded as Board Member at enGene Therapeutics Inc. (ENGN). The newest filing on record that lists Philip Astley-Sparke as Board Member at enGene Therapeutics Inc. (ENGN) is dated May 8, 2026. enGene Therapeutics Inc. reported in an 8-K filed July 8, 2025 that Philip Astley-Sparke was appointed director, effective July 8, 2025. enGene Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at enGene Therapeutics Inc. includes Ron Cooper (CEO and Board Member), Ronald H. W. Cooper (CEO and Board Member), Ronald H.W. Cooper (CEO and Board Member) and 7 others.
“the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Philip Astley-Sparke to the Board as a director to fill such vacancy effective as of July 8, 2025, with Mr. Astley-Sparke to serve for the remainder of Mr. Bos's term expiring at the Company's 2026 annual general meeting of the shareholders, or until Mr. Astley-Sparke's successor is duly elected and appointed or his earlier death, resignation, or removal.”
Affiliation history
-
Current
Start not stated–present
Last confirmed May 8, 2026
Company network
Leadership on record at enGene Therapeutics Inc.
- Ron Cooper CEO, Board Member
- Ronald H. W. Cooper CEO, Board Member
- Ronald H.W. Cooper CEO, Board Member
- Ryan Daws CFO
- Alex Nichols COO
- Alexander Nichols COO
- Dr. Alex Nichols COO
- Anthony Cheung CTO
- Joan Connolly CTO
- Dr. William Grossman Board Member